Geode Capital Management, LLC Immunic, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 952,290 shares of IMUX stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

952,290

Previous 945,533 0.71%

Holding current value

$1.05 Million

Previous $1.56 Million 38.97%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$1.0 - $1.61 $6,757 - $10,878	6,757 Added 0.71%	952,290 $952,000
Q3 2024 Nov 12, 2024	BUY	$1.08 - $1.95 $10,017 - $18,086	9,275 Added 0.99%	945,533 $1.56 Million
Q2 2024 Aug 09, 2024	BUY	$0.98 - $1.44 $39,799 - $58,481	40,612 Added 4.53%	936,258 $1.04 Million
Q1 2024 May 13, 2024	BUY	$1.14 - $1.53 $544,957 - $731,390	478,033 Added 114.47%	895,646 $1.18 Million
Q4 2023 Feb 13, 2024	BUY	$0.97 - $1.6 $20,339 - $33,550	20,969 Added 5.29%	417,613 $626,000
Q3 2023 Nov 13, 2023	BUY	$1.35 - $2.87 $58,635 - $124,655	43,434 Added 12.3%	396,644 $583,000
Q2 2023 Aug 11, 2023	SELL	$1.33 - $2.51 $20,515 - $38,716	-15,425 Reduced 4.18%	353,210 $886,000
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $132,507 - $281,701	98,154 Added 36.29%	368,635 $549,000
Q4 2022 Feb 13, 2023	BUY	$1.13 - $10.8 $60,697 - $580,122	53,715 Added 24.78%	270,481 $378,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $5,367 - $9,821	1,789 Added 0.83%	216,766 $684,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $12.25 $456,923 - $1.79 Million	-145,982 Reduced 40.44%	214,977 $745,000
Q1 2022 May 13, 2022	BUY	$9.54 - $14.26 $390,748 - $584,075	40,959 Added 12.8%	360,959 $4.08 Million
Q4 2021 Feb 11, 2022	BUY	$7.34 - $10.25 $44,384 - $61,981	6,047 Added 1.93%	320,000 $3.06 Million
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $445,841 - $736,053	55,384 Added 21.42%	313,953 $2.78 Million
Q2 2021 Aug 13, 2021	BUY	$11.76 - $16.85 $1.11 Million - $1.59 Million	94,139 Added 57.25%	258,569 $3.17 Million
Q1 2021 May 12, 2021	BUY	$14.21 - $25.3 $171,983 - $306,205	12,103 Added 7.95%	164,430 $2.62 Million
Q4 2020 Feb 12, 2021	BUY	$14.8 - $20.37 $342,338 - $471,178	23,131 Added 17.9%	152,327 $2.33 Million
Q3 2020 Nov 13, 2020	BUY	$11.74 - $22.0 $1.11 Million - $2.08 Million	94,614 Added 273.59%	129,196 $2.4 Million
Q2 2020 Aug 13, 2020	BUY	$5.67 - $15.86 $196,079 - $548,470	34,582 New	34,582 $419,000
Q4 2019 Feb 13, 2020	SELL	$6.4 - $10.23 $67,366 - $107,680	-10,526 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$10.0 - $17.01 $850 - $1,445	-85 Reduced 0.8%	10,526 $105,000
Q2 2019 Aug 14, 2019	BUY	$7.88 - $33.2 $83,614 - $352,285	10,611 New	10,611 $121,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

51.2M

Call Options Held

824K

Put Options Held

354K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33.6M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Immunic, Inc. Transaction History